Cardiovascular trials

Trials closed

LILACS

The mainstay for treatment for acute coronary syndrome (ACS) focuses on re-establishing and maintaining the patency of vessels following coronary plaque disruption, through the use of anti-platelets and anticoagulants. Despite advances in…

OPERA-CKD

This is a pilot proposal to understand the changes in physiology in patients undergoing scheduled therapy with Darbepoetin as part of their normal NHS care. It is therefore an observational pilot study of changes in physiology before and after…